title: Investigational medications in the treatment of alopecia.
abstract: Androgenetic alopecia (hereditary thinning) is the most common cause of hair loss in both men and women. Chemotherapy-induced alopecia is another distressing cause of hair loss. With a better understanding of follicular biology and the signals responsible for hair growth and regression, targeted therapies for hair loss are being investigated. This review summarises investigational medications for androgenetic and chemotherapy-induced alopecia that are in preclinical stages or later.
authors.affiliation: Northeastern Ohio Universities College of Medicine, USA.
authors.forename: Georgann A
authors.initials: GA
authors.lastname: Poulos
authors.forename: Paradi
authors.initials: P
authors.lastname: Mirmirani
mesh_terms: D000505:Alopecia / Q000139:chemically induced / Q000188:drug therapy* / Q000235:genetics; D000726:Androgen Antagonists / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D015507:Drugs, Investigational